TIMM17A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.176000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.914800E-01
Normal-vs-Stage2
1.821000E-01
Normal-vs-Stage3
4.777000E-01
Normal-vs-Stage4
6.416100E-02
Stage1-vs-Stage2
9.030200E-01
Stage1-vs-Stage3
9.741200E-01
Stage1-vs-Stage4
5.695200E-01
Stage2-vs-Stage3
8.739400E-01
Stage2-vs-Stage4
4.420400E-01
Stage3-vs-Stage4
6.025400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.481200E-01
Normal-vs-AfricanAmerican
1.968410E-02
Normal-vs-Asian
1.291600E-01
Caucasian-vs-AfricanAmerican
1.294200E-01
Caucasian-vs-Asian
4.982400E-01
AfricanAmerican-vs-Asian
3.426000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.180800E-01
Normal-vs-Female
2.174000E-01
Male-vs-Female
5.318400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.025800E-01
Normal-vs-Age(41-60Yrs)
2.008600E-01
Normal-vs-Age(61-80Yrs)
2.393800E-01
Normal-vs-Age(81-100Yrs)
3.890400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.255200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.532600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.152000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.810400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.846000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.014600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.663600E-01
Normal-vs-Daily Drinker
4.000000E-01
Normal-vs-Weekly Drinker
1.319360E-01
Normal-vs-Occasional Drinker
1.549390E-01
Normal-vs-Social Drinker
4.078600E-01
Non Drinker-vs-Daily Drinker
5.592400E-01
Non Drinker-vs-Weekly Drinker
4.531400E-01
Non Drinker-vs-Occasional Drinker
2.816400E-01
Non Drinker-vs-Social Drinker
5.823200E-01
Daily Drinker-vs-Weekly Drinker
2.293000E-01
Daily Drinker-vs-Occasional Drinker
1.386630E-01
Daily Drinker-vs-Social Drinker
9.778200E-01
Weekly Drinker-vs-Occasional Drinker
7.880000E-01
Weekly Drinker-vs-Social Drinker
2.538200E-01
Occasional Drinker-vs-Social Drinker
1.753430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.448400E-01
Normal-vs-Grade 2
7.218200E-02
Normal-vs-Grade 3
4.155800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.314000E-02
Grade 1-vs-Grade 3
7.329700E-02
Grade 1-vs-Grade 4
3.448400E-01
Grade 2-vs-Grade 3
9.024800E-01
Grade 2-vs-Grade 4
7.218200E-02
Grade 3-vs-Grade 4
4.155800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.559000E-01
Normal-vs-NonDiabetic
2.185800E-01
Diabetic-vs-NonDiabetic
3.148800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.005010E-01
Normal-vs-NoPancreatitis
2.492800E-01
Pancreatitis-vs-NoPancreatitis
8.212200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.207780E-01
Normal-vs-N1
2.243200E-01
N0-vs-N1
5.182600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.268300E-02
Normal-vs-TP53-NonMutant
4.247400E-01
TP53-Mutant-vs-TP53-NonMutant
4.842800E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
